Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Acute myelomonocytic leukemia

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Acute myelomonocytic leukemia (AMML) is a cancer that typically develops in the bone marrow and blood of older individuals.  AMML is one type of acute myeloid leukemia, a group of blood cancers that occur when the amount of white blood cells increases rapidly.  Symptoms of AMML often include fatigue (due to anemia) or easy bruising or bleeding (due to thrombocytopenia).  The cause of AMML is currently unknown.  Treatment typically consists of chemotherapy.[1]
Last updated: 2/12/2013


  1. American Cancer Society. Detailed Guide. Leukemia - Acute Myeloid (Myelogenous). January 2013; Accessed 2/12/2013.
Your Questions Answered
by the Genetic and Rare Diseases Information Center

1 question(s) from the public on Acute myelomonocytic leukemia have been answered. See questions and answers. You can also submit a new question.
On this page

In Depth Information

  • PubMed is a searchable database of medical literature and lists journal articles that discuss Acute myelomonocytic leukemia. Click on the link to view a sample search on this topic.